Role of Matrix Metalloproteinases-1 and -2 in Interleukin-13–Suppressed Elastin in Airway Fibroblasts in Asthma

Abstract

ORCID ID: 0000-0001-7054-794X (J.L.I.). AbstractElastin synthesis and degradation in the airway and lung parenchyma contribute to airway mechanics, including airway patency and elastic recoil. IL-13 mediates many features of asthma pathobiology, including airway remodeling, but the effects of IL-13 on elastin architecture in the airway wall are not known. We hypothesized that IL-13 modulates elastin expression in airway fibroblasts from subjects with allergic asthma. Twenty-five subjects with mild asthma (FEV 1 , 89 6 3% predicted) and 30 normal control subjects (FEV 1 , 102 6 2% predicted) underwent bronchoscopy with endobronchial biopsy. Elastic fibers were visualized in airway biopsy specimens using Weigert's resorcin-fuchsin elastic stain. Airway fibroblasts were exposed to IL-13; a pan-matrix metalloproteinase (MMP) inhibitor (GM6001); specific inhibitors to MMP-1, -2, -3, and -8; and combinations of IL-13 with MMP inhibitors in separate conditions in serum-free media for 48 hours. Elastin (ELN) expression as well as MMP secretion and activity were quantified. Results of this study show that elastic fiber staining of airway biopsy tissue was significantly associated with methacholine PC 20 (i.e., the provocative concentration of methacholine resulting in a 20% fall in FEV 1 levels) in patients with asthma. IL-13 significantly suppressed ELN expression in asthmatic airway fibroblasts as compared with normal control fibroblasts. The effect of IL-13 on ELN expression was significantly correlated with postbronchodilator FEV 1 /FVC in patients with asthma. MMP inhibition significantly stimulated ELN expression in patients with asthma as compared with normal control subjects. Specific inhibition of MMP-1 and MMP-2, but not MMP-3 or MMP-8, reversed the IL-13-induced suppression of ELN expression. In asthma, MMP-1 and MMP-2 mediate IL-13-induced suppression of ELN expression in airway fibroblasts.

Atopic asthma after rhinovirus‐induced wheezing is associated with DNA methylation change in the SMAD3 gene promoter

“…HLA‐G gene, 33 kb upstream from the differentially methylated region, is an asthma susceptibility gene, and its expression is induced by allergens . Several other differentially methylated sites were also in the proximity of genes, such as ELN or CYTIP, previously linked to lung or immune cell functions, or viral infections, therefore having potential functional significance in the atopic asthma.…”

Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets

“…77 In vitro work has implicated IL-13 as a potent suppressor of elastin mRNA expression through a pathway that involves the secretion of MMP-1 and MMP-2. 123 The later stages of asthma may thus start to resemble emphysema, shifting asthma down the airways spectrum to ACOS.…”

Where does current and future pediatric asthma treatment stand? Remodeling and inflammation: Bird's eye view

“…Elastin is another component of the lung architecture and the decrease in elastin has been shown to be associated with airway narrowing, airway hyperreactivity, and remodeling. IL‐13 one of the major inflammatory cytokines in asthma has been shown to decrease elastin mRNA expression in airway fibroblasts …”